| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| DeltaGen, Inc. |
| 1003 Hamilton Avenue, Menlo Park, CA 94025 * (650) 752-0200 |
| Business Description | The company has developed technology to convert raw genetic data into mamalian gene function information to help pharmaceutical and biotechnology companies expedite the drug delivery process. |
| Offering Information Company has | |||
| Trading As | DGEN (NASNTL) | Industry | Service (SIC 8731) |
| Type of Stock Offered | Common Shares | Filing Date | 4/13/00 |
| Domestic Shares Offered | 7,000,000 | Offer Date | 8/2/00 |
| Foreign Shares Offered | 0 | Filing Range | $13.00 - $15.00 |
| Company Shares | 7,000,000 | Offer Price | $15.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $1.050 |
| Gross Proceeds | $105,000,000 | Selling | $0.630 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 28,800,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Salomon Smith Barney | Lead Manager | (212) 723-7300 |
| Robertson, Stephens & Company | Co-manager | (415) 989-8500 |
| U.S. Bancorp Piper Jaffray | Co-manager | (612) 342-6220 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 12/31/99 | ||||
| Revenues | - | - | 0.000 | 0.381 | 1.240 | - | - |
| Income from Oper. | - | - | -1.295 | -3.617 | -13.836 | - | - |
| Net Income | - | - | -1.255 | -3.352 | -13.847 | - | - |
| E.P.S | - | - | - | -9.130 | -14.790 | - | - |
| Revenue Growth (%) | - | - | - | 225.459 | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -7.25 | - | - | ||||
| Cash Flow - Inv. | -3.47 | - | - | ||||
| Cash Flow - Fin. | 2.93 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/99 | Financial Ratios | ||||
| Total Assets | 6.77 | Current Assets | 1.64 | Current Ratio | 0.30 |
| Total Liab. | 22.14 | Current Liab. | 5.44 | Debt Ratio | 326.85% |
| Total Equity | -15.37 | Working Cap. | -3.80 | Debt to Equity Ratio | - |
| Cash | 0.85 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for expansion of product and technology development, growth of sales and marketing organization, investment in intellectual property protection, working capital and general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Pillsbury Madison & Sutro |
| Bank's Law Firm | Cravath, Swaine & Moore |
| Registrar/Transfer Agent | BankBoston |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Entities affiliated with The Sprout Group | 28.70 | |
| Entities affiliated with boston Millennia Partners | 28.40 | |
| Stipa Investments, L.P. | 11.80 | |
| Note: represents ownership of 5% or more prior to the offering. | ||